Catalent Inc (CTLT.N)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|53||2016||Chairman of the Board, President, Chief Executive Officer|
|51||2012||Chief Financial Officer, Executive Vice President|
|52||2013||President - Softgel Technologies|
|45||2015||President - Clinical Supply Services|
|51||2013||President - Drug Delivery Solutions|
- BRIEF-Catalent Q1 earnings per share $0.03
- BRIEF-Catalent completes repricing and extension of credit agreement
- BRIEF-Catalent announces pricing of private offering of senior unsecured notes due 2026
- U.S. small-cap firms look to spend tax savings on tech, not jobs |
- BRIEF-Catalent launches private offering of $450 mln of senior unsecured notes due 2026